Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Hepatitis C Pill Race Makes BioLineRx a Buyout Target: Israel Overnight
Bloomberg
Wednesday, January 25, 2012 - 10:37am
tags:
hepatitis C, BioLineRx, M&A
Pfizer’s Lipitor Plan Might Not Be ‘Worth It,’ Watson CEO Says
Bloomberg
Wednesday, January 25, 2012 - 10:34am
tags:
Pfizer, Lipitor, generics, Pharma CEOs, Watson, Paul Bisaro
Roche Offers $5.7 Billion for Illumina
Bloomberg
Wednesday, January 25, 2012 - 10:25am
tags:
Roche, Illumina, hostile bid, M&A
XenoPort says Glaxo breached Horizant contract
Reuters
Wednesday, January 25, 2012 - 10:24am
tags:
XenoPort, GSK, Horizant, RLS, restless legs syndrome
Johnson & Johnson won't restart Montco Tylenol plant until at least 2013
Philadelphia Inquirer, PA
Wednesday, January 25, 2012 - 10:24am
tags:
JNJ, Tylenol, recalls
Swiss drug maker Novartis sees Q4 profit down 47 percent to $1.2B on charges
Yahoo/AP
Wednesday, January 25, 2012 - 10:22am
tags:
Novartis, earnings
FDA Turns Down Expanded Use of Mercks’ Vytorin and Zetia
Bloomberg
Wednesday, January 25, 2012 - 9:32am
tags:
FDA, Vytorin, Merck, Zetia, kidney disease
Abbott Laboratories profit rises by 12%
Marketwatch
Wednesday, January 25, 2012 - 9:31am
tags:
earnings, Abbott Laboratories
Bristol-Myers Warning Ignored on Steroid Shots Tied to Deaths
Bloomberg
Wednesday, January 25, 2012 - 9:30am
tags:
Bristol-Myers Squibb, FDA, Kenalog
Takeda’s Daxas Fails to Win U.K. Cost Agency’s Backing
Bloomberg
Wednesday, January 25, 2012 - 9:29am
tags:
Daxas, Takeda, UK, COPD
Did Stiefel undervalue employee shares before GSK buyout?
Fierce Pharma
Tuesday, January 24, 2012 - 5:34pm
tags:
Stiefel Labs, GSK
Watson Buys Ascent Pharmahealth
Yahoo/Zacks
Tuesday, January 24, 2012 - 5:14pm
tags:
Ascent Pharmahealth, Watson Pharmaceuticals, M&A
Big Pharma’s New Drugs Counteract Patent Cliff: Moody’s
Barron's
Tuesday, January 24, 2012 - 5:12pm
tags:
patents, patent cliff, JNJ, Novartis
The Good and Bad of Johnson & Johnson
Motley Fool
Tuesday, January 24, 2012 - 5:11pm
tags:
JNJ
Gilead not immune to concern over Truvada’s wider HIV use
FT.com
Tuesday, January 24, 2012 - 11:22am
tags:
HIV, Truvada, Gilead
Insmed shares spike after FDA lifts hold
Fierce Biotech
Tuesday, January 24, 2012 - 11:19am
tags:
Insmed, FDA, Arikace, antibiotics
Novo crafts fast-track R&D model for new diabetes drug unit
Fierce Biotech
Tuesday, January 24, 2012 - 11:18am
tags:
Novo Nordisk, R&D, diabetes
Pfizer Dividend Capture With A Call Option Hedge
Seeking Alpha
Tuesday, January 24, 2012 - 11:17am
tags:
Pfizer, dividends, call options
Watson 2011 earnings jump on generic drug launches
Yahoo/AP
Tuesday, January 24, 2012 - 11:16am
tags:
Watson, earnings
J&J earnings hit by litigation and recalls
FT.com
Tuesday, January 24, 2012 - 10:58am
tags:
earnings, JNJ, recalls

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.